LivaNova LIVN Cardiopulmonary — Goodwill
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by LivaNova in its filing.
Tagged under the XBRL concept us-gaap:Goodwill.
The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about LivaNova's cardiopulmonary — goodwill.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is LivaNova's cardiopulmonary — goodwill?
- LivaNova (LIVN) reported cardiopulmonary — goodwill of $386.84M in Q1 2026.
- How has LivaNova's cardiopulmonary — goodwill changed year-over-year?
- LivaNova's cardiopulmonary — goodwill increased by 6.5% year-over-year, from $363.16M to $386.84M.
- What is the long-term trend for LivaNova's cardiopulmonary — goodwill?
- Over 3 years (2022 to 2025), LivaNova's cardiopulmonary — goodwill has grown at a 1.4% compound annual growth rate (CAGR), from $1.48B to $1.54B.
- What does cardiopulmonary — goodwill mean?
- Represents the intangible asset value recognized when the cardiopulmonary segment acquires another business for a price exceeding the fair market value of its net identifiable assets. It serves as a measure of the premium paid for expected future synergies and brand value.